In addition to the fact that immunostaining for EIF4G2 protein in tissue is a more accurate description of the relative levels of EIF4G2 specifically within the tumor tissue compared to measurement of total mRNA levels, the discrepancy in the data is consistent with EIF4G2 having different functions in different cancer subtypes. Here, EIF4G2 is linked to cancer.